Skip to main content
Journal cover image

Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application.

Publication ,  Journal Article
Benrashid, E; McCoy, CC; Youngwirth, LM; Kim, J; Manson, RJ; Otto, JC; Lawson, JH
Published in: Methods
April 15, 2016

Since the development of a dependable and durable synthetic non-autogenous vascular conduit in the mid-twentieth century, the field of vascular surgery has experienced tremendous growth. Concomitant with this growth, development in the field of bioengineering and the development of different tissue engineering techniques have expanded the armamentarium of the surgeon for treating a variety of complex cardiovascular diseases. The recent development of completely tissue engineered vascular conduits that can be implanted for clinical application is a particularly exciting development in this field. With the rapid advances in the field of tissue engineering, the great hope of the surgeon remains that this conduit will function like a true blood vessel with an intact endothelial layer, with the ability to respond to endogenous vasoactive compounds. Eventually, these engineered tissues may have the potential to supplant older organic but not truly biologic technologies, which are used currently.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Methods

DOI

EISSN

1095-9130

Publication Date

April 15, 2016

Volume

99

Start / End Page

13 / 19

Location

United States

Related Subject Headings

  • Tissue Engineering
  • Humans
  • Cardiovascular Diseases
  • Blood Vessel Prosthesis
  • Animals
  • 3101 Biochemistry and cell biology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Benrashid, E., McCoy, C. C., Youngwirth, L. M., Kim, J., Manson, R. J., Otto, J. C., & Lawson, J. H. (2016). Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application. Methods, 99, 13–19. https://doi.org/10.1016/j.ymeth.2015.07.014
Benrashid, Ehsan, Christopher C. McCoy, Linda M. Youngwirth, Jina Kim, Roberto J. Manson, James C. Otto, and Jeffrey H. Lawson. “Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application.Methods 99 (April 15, 2016): 13–19. https://doi.org/10.1016/j.ymeth.2015.07.014.
Benrashid E, McCoy CC, Youngwirth LM, Kim J, Manson RJ, Otto JC, et al. Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application. Methods. 2016 Apr 15;99:13–9.
Benrashid, Ehsan, et al. “Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application.Methods, vol. 99, Apr. 2016, pp. 13–19. Pubmed, doi:10.1016/j.ymeth.2015.07.014.
Benrashid E, McCoy CC, Youngwirth LM, Kim J, Manson RJ, Otto JC, Lawson JH. Tissue engineered vascular grafts: Origins, development, and current strategies for clinical application. Methods. 2016 Apr 15;99:13–19.
Journal cover image

Published In

Methods

DOI

EISSN

1095-9130

Publication Date

April 15, 2016

Volume

99

Start / End Page

13 / 19

Location

United States

Related Subject Headings

  • Tissue Engineering
  • Humans
  • Cardiovascular Diseases
  • Blood Vessel Prosthesis
  • Animals
  • 3101 Biochemistry and cell biology
  • 1103 Clinical Sciences